Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
MRI lesions: a surrogate for relapses in multiple sclerosis?
Standing Data Disproves Biomechanical Mechanism for Balance-Based Torso-Weighting.
Brain stem infarction associated with familial Mediterranean fever and central nervous system vasculitis.
No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis.
Aerobic exercise in people with multiple sclerosis: its feasibility and secondary benefits.
RNA sequencing of microglia and monocyte-derived macrophages from mice with experimental autoimmune encephalomyelitis illustrates a changing phenotype with disease course.
Tumefactive demyelinating disease with isolated spinal cord involvement.
Functional connectivity underlying postural motor adaptation in people with multiple sclerosis.
Anti-Inflammatory Potential of Newly Synthesized 4-[(Butylsulfinyl)methyl]-1,2-benzenediol in Lipopolysaccharide-Stimulated BV2 Microglia.
Unethical for neurologists not to offer patients with multiple sclerosis chemotherapy with autologous stem cell support.
Mind the gap! Lay and medical perceptions of risks associated with the use of alternative treatment and conventional medicine.
Anthocyanin effects on microglia M1/M2 phenotype: Consequence on neuronal fractalkine expression.
Overview of the management of relapsing-remitting multiple sclerosis and practical recommendations.
Neuroinflammatory signals enhance the immunomodulatory and neuroprotective properties of multipotent adult progenitor cells.
Reproducibility of brain metabolite concentration measurements in lesion free white matter at 1.5 T.
A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders.
Targeting FcRn for therapy: From live cell imaging to in vivo studies in mice.
Low degree of cortical pathology is associated with benign course of multiple sclerosis.
Multiple sclerosis: Defect in peripheral B-cell tolerance identified in MS.
Utility of the Canadian Treatment Optimization Recommendations (TOR) in MS Care.
Differential effects of genetic susceptibility factors in males and females with multiple sclerosis.
Multiple sclerosis: Gene-vitamin D interactions likely to influence pathogenesis and risk of relapse in multiple sclerosis.
The effect of wheelchair use on the quality of life of persons with multiple sclerosis.
Regulation of immune cell infiltration into the CNS by regional neural inputs explained by the gate theory.
Muscle-specific kinase antibody positive myaesthenia gravis and multiple sclerosis co-presentation: A case report and literature review.
Pages
« first
‹ previous
…
554
555
556
557
558
559
560
561
562
…
next ›
last »